Macrophage metabolic exhaustion and PANoptotic cell death drive chronic tissue inflammation in rheumatoid arthritis
Immunity · 2026-04 · 59 (4) · 970-987.e6
DOI: 10.1016/j.immuni.2026.01.019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, 2026-04. Verfasst von Tao Huang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Mayo Clinic Alix School of Medicine, Rochester, MN 55905, USA; Department of Immunology, Mayo Clinic College of Medicine and …. Hauptthemen laut MEDLINE: Macrophages, Arthritis, Rheumatoid, Inflammation. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, NHLBI NIH HHS, NIAMS NIH HHS.
Abstract (Originalsprache)
In the autoimmune disease rheumatoid arthritis, the inflammatory response evolves from protective to pathogenic, causing tissue destruction. Rheumatoid synovitis persists despite the presence of pro-repair SELENOPhiMerTK+CD206+ macrophages, suggesting that these cells acquire pro-arthritogenic functions. Patient-derived synovial SELENOPhiMerTK+CD206+ macrophages produced high concentrations of the complement component C1q and concurrently expressed its receptor, C1QBP. Stimulation of these macrophages with C1q induced metabolic exhaustion, characterized by diminished ATP production, cleavage of mitochondrial nicotinamide adenine dinucleotide (NAD), and accumulation of cyclic ADP ribose (cADPR). This metabolic crisis was driven by the mitochondrial enzyme Sterile alpha and Toll/interleukin-1 receptor (TIR) motif containing 1 (SARM1), which catalyzed the conversion of NAD into cADPR, triggering PANoptotic and pro-inflammatory macrophage death. In vivo experiments demonstrated that C1q treatment exacerbated synovitis, whereas SARM1 inhibition conferred therapeutic benefit. These findings identify the NAD+ hydrolase SARM1 as a marker of metabolically stressed macrophages and an executor of pro-inflammatory macrophage death during autoimmune tissue inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Mayo Clinic Alix School of Medicine, Rochester, MN 55905, USA; Department of Immunology, Mayo Clinic College of Medicine and Science, Rochester, MN 55905, USA; Department of Cardiology, Mayo Clin…
- Department of Orthopedic Surgery, Mayo Clinic Alix School of Medicine, Rochester, MN 55905, USA.
- Department of Pathology, School of Medicine, Stanford University, Stanford, CA 94305, USA.
- Department of Medicine, Mayo Clinic Alix School of Medicine, Rochester, MN 55905, USA; Department of Immunology, Mayo Clinic College of Medicine and Science, Rochester, MN 55905, USA; Department of Medicine, School of M…
Förderung
- NIAID NIH HHS
- NHLBI NIH HHS
- NIAMS NIH HHS
- NIA NIH HHS
- National Institutes of Health National Institute of Allergy and Infectious Diseases
- National Heart Lung and Blood Institute
- National Institutes of Health
Zitieren
APA
Huang, T., Takashima, Y., Kumar, J., Morales, J., Le, K., Hu, Z., Rubino, S., Trousdale, R. T., Berry, G. J., Goronzy, J. J., & Weyand, C. M. (2026). Macrophage metabolic exhaustion and PANoptotic cell death drive chronic tissue inflammation in rheumatoid arthritis. Immunity, 59(4), 970-987.e6. https://doi.org/10.1016/j.immuni.2026.01.019
Vancouver
Huang T, Takashima Y, Kumar J, Morales J, Le K, Hu Z, et al. Macrophage metabolic exhaustion and PANoptotic cell death drive chronic tissue inflammation in rheumatoid arthritis. Immunity. 2026;59(4):970-987.e6. doi:10.1016/j.immuni.2026.01.019
BibTeX
@article{Huang2026,
author = {Huang, Tao and Takashima, Yoshinori and Kumar, Jitendra and Morales, Jose and Le, Kevin and Hu, Zhensheng and Rubino, Selene and Trousdale, Robert T and Berry, Gerald J and Goronzy, Jorg J and Weyand, Cornelia M},
title = {Macrophage metabolic exhaustion and PANoptotic cell death drive chronic tissue inflammation in rheumatoid arthritis},
journal = {Immunity},
year = {2026},
volume = {59},
number = {4},
pages = {970--987.e6},
doi = {10.1016/j.immuni.2026.01.019}
}
EUVIMED